Communicating With Patients on the Safety of JAK Inhibitors in Atopic Dermatitis

Communicating With Patients on the Safety of JAK Inhibitors in Atopic Dermatitis

Experts discuss how to effectively communicate the safety of JAK inhibitors to patients with atopic dermatitis, including how to address the FDA boxed warning by emphasizing the balance of risks and benefits and tailoring the conversation based on individual patient concerns and risk factors.

Why Atopic Dermatitis Treatment is Not “One Size Fits All,” According to Jiyeon Oh

Jiyeon Oh’s research confirms that a personalized approach is needed to treat all complexities associated with AD.

What is the optimal brand communication on social media? Our columnist looks at it from the scientific perspective – and comes to a much more differentiated result than the AI. The post One size doesn't fit all first appeared on sales economy.